资讯
The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...
9 小时
Zacks Investment Research on MSNOrganon (OGN) Ascends But Remains Behind Market: Some Facts to NoteOrganon (OGN) closed at $12.20 in the latest trading session, marking a +0.66% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.74%. Elsewhere, the Dow gained ...
Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place ...
Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...
The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...
In the high-stakes world of pharmaceutical manufcturing, where regulatory compliance meets razor-thin margins and patient safety, one industry leader is redefining what Lean transformation means in ...
Amid growing anxiety over tariffs, one medical center has warned its suppliers that any sudden price hikes attributed to the ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at ...
Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.
Haitao Li, chair of the supply chain analytics department at the University of Missouri-St. Louis, says that the Trump ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果